TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CSPC Pharmaceutical Group ( (HK:1093) ) has issued an announcement.
CSPC Pharmaceutical Group Limited has appointed Mr. QU Zhiyong as an Executive Director effective from November 21, 2025. Mr. QU, who has been with the company since 2004 and currently serves as the General Manager of the Hong Kong Head Office Management Centre, will bring his extensive financial expertise to the Board. This strategic appointment is expected to strengthen the company’s leadership and enhance its financial operations, potentially impacting its market positioning positively.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$11.05 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on developing, manufacturing, and selling pharmaceutical products, with a significant emphasis on financial management and investment within its subsidiaries.
Average Trading Volume: 147,790,246
Technical Sentiment Signal: Buy
Current Market Cap: HK$87.08B
Learn more about 1093 stock on TipRanks’ Stock Analysis page.